Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapyFrancesco Ceci, Désirèe Deandreis, Valeria Chiofalo et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 26
Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or PersistenceGuido Rovera, Désirèe Deandreis, Paolo Gontero et al.|Diagnostics|2022Cited by 7
Event-Free Survival after 68Ga-PSMA-11 PET/CT in recurrent Hormone-Sensitive Prostate Cancer (HSPC) patients eligible for Salvage Therapy.Francesco Ceci, Désirèe Deandreis, Roberto Passera et al.|Research Square|2021Cited by 2
Comparison of Digital versus Analog 68Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical TreatmentGuido Rovera, Désirèe Deandreis, Monica Finessi et al.|Diagnostics|2023Cited by 2